About Newborn Screening Laboratories

At a glance

CDC's Newborn Screening Laboratories help assure the early and accurate detection of treatable newborn diseases.

More Information

An image a blood spot testing on newborn

Newborn Screening Quality Assurance Program

The Newborn Screening Quality Assurance Program (NSQAP) develops analytical methods to measure substances in dried blood spots (DBSs) and produces certified DBS quality-control and reference materials for newborn screening tests. Because of NSQAP, parents and doctors in the United States and worldwide can trust the results of newborn screening tests.

Newborn Screening Quality Assurance Program | Laboratory Quality Assurance Programs | CDC

To access previous newborn quality assurance reports: Program Reports | Newborn Screening | CDC

Access the NSQAP Participant Portal

A2LA Accredited Proficiency Testing Provider‎

CDC's Newborn Screening and Molecular Biology Branch (NSMBB) has been granted ISO/IEC 17043 accreditation by the American Association for Laboratory Accreditation (A2LA). Accreditation was achieved after a thorough review of its quality management system and competence to develop and administer specific proficiency testing protocols. NSMBB's Newborn Screening Quality Assurance Program (NSQAP) web-based proficiency testing programs are included in the A2LA Scope of Accreditation. Testing for Glucose-6-phosphate Dehydrogenase and NSMBB non-web-based proficiency testing programs are not included in the scope of accreditation. Please consult A2LA Certificate #4190.02 for a list of accredited NSMBB proficiency testing programs.

Supporting state newborn screening laboratories

CDC enhances nation-wide capacity and capability to conduct newborn screening by providing resources and technical assistance to state public health laboratories.

Supporting State Newborn Screening Laboratories | Newborn Screening | CDC

Emergency preparedness for newborn screening programs

CDC helps state newborn screening programs be prepared for emergencies that could disrupt normal operations.

Emergency Preparedness for Newborn Screening Programs | Newborn Screening | CDC

Enhancing data-driven disease detection in Newborns

The Enhancing Data-driven Disease Detection in Newborns (ED3N) pilot program aims to provide a national data platform that will improve the quality and interpretation of newborn screening results.

Enhancing Data-Driven Disease Detection in Newborns | Newborn Screening | CDC

Contacts

Please note that CDC cannot respond to questions about individual medical cases, provide second opinions, or make specific recommendations regarding therapy. Those issues should be addressed directly with your health care provider.

E-mail: CDC-INFO

Phone: CDC Health Line 1-800-CDC-INFO (1-800-232-4636)

Address:
Division of Laboratory Sciences
Mail Stop F-204770 Buford Highway
NE Atlanta, GA 30341-3724